Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease

作者: Takeshi Nakanishi , Yoshinaga Otaki , Yukiko Hasuike , Masayoshi Nanami , Reiko Itahana

DOI: 10.1053/AJKD.2002.36320

关键词:

摘要: Abstract Background: Plasma total homocysteine (tHcy) level is increased in patients with renal disease, parallel to serum creatinine concentration. In failure, the final product of sulfated amino acid metabolism, sulfate, also accumulates as function declines. We hypothesized that elevation sulfate could cause hyperhomocysteinemia and tested relation between tHcy both urinary excretion plasma levels sulfate. Methods: Forty disease were divided into three groups: without failure (nRF; clearance [CCr] ≥ 80 mL/min/1.73 m 2 [≥1.33 mL/s/1.73 ]), mild (mRF; > CCr 25 [1.33 0.42 severe (sRF; [ ]). Daily tHcy, cysteine (tCys), measured. A healthy control (HC) group was tested. Serum methionine, taurine, vitamin B 12 , folate determined disease. Results: concentrations groups mRF sRF greater than HC group. tCys nRF Hcy Cys did not differ among four groups. urine urea nitrogen significantly less Multiple regression analyses showed (β = 0.40) 0.43) independently associated level; parameters, only daily −0.52) level. Conclusion: The elevated level, accordance function, Decreased excretion, which might intake or protein, may increase levels. Am J Kidney Dis 40:909-915. © 2002 by National Foundation, Inc.

参考文章(29)
K S Mccully, Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. American Journal of Pathology. ,vol. 56, pp. 111- 128 ,(1969)
Anne B. Guttormsen, Jørn Schneede, Torunn Fiskerstrand, Per M. Ueland, Helga M. Refsum, Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. Journal of Nutrition. ,vol. 124, pp. 1934- 1941 ,(1994) , 10.1093/JN/124.10.1934
R Riezler, W Zidek, M Tepel, K Langer, H Raidt, U Graefe, J Bachmann, Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. Journal of The American Society of Nephrology. ,vol. 6, pp. 121- 125 ,(1995) , 10.1681/ASN.V61121
Steven R. Lentz, M. René Malinow, Donald J. Piegors, Monica Bhopatkar-Teredesai, Frank M. Faraci, Donald D. Heistad, Consequences of Hyperhomocyst(e)inemia on Vascular Function in Atherosclerotic Monkeys Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 17, pp. 2930- 2934 ,(1997) , 10.1161/01.ATV.17.11.2930
A B Guttormsen, P M Ueland, I Nesthus, O Nygård, J Schneede, S E Vollset, H Refsum, Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study. Journal of Clinical Investigation. ,vol. 98, pp. 2174- 2183 ,(1996) , 10.1172/JCI119024
J Loscalzo, The oxidant stress of hyperhomocyst(e)inemia. Journal of Clinical Investigation. ,vol. 98, pp. 5- 7 ,(1996) , 10.1172/JCI118776
Richard M. Freeman, Carl J. Richards, Studies on sulfate in end-stage renal disease Kidney International. ,vol. 15, pp. 167- 175 ,(1979) , 10.1038/KI.1979.22
Anne B. Guttormsen, Per M. Ueland, Einar Svarstad, Helga Refsum, Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure Kidney International. ,vol. 52, pp. 495- 502 ,(1997) , 10.1038/KI.1997.359
A. Chico, A. Pérez, A. Córdoba, R. Arcelús, G. Carreras, A. de Leiva, F. González-Sastre, F. Blanco-Vaca, Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. ,vol. 41, pp. 684- 693 ,(1998) , 10.1007/S001250050969
Ali Moustapha, Anjan Gupta, Killian Robinson, Kristopher Arheart, Donald W. Jacobsen, Martin J. Schreiber, Vincent W. Dennis, Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis Kidney International. ,vol. 55, pp. 1470- 1475 ,(1999) , 10.1046/J.1523-1755.1999.00378.X